TB catch-up plan underway in Western Cape but old challenges linger

TB catch-up plan underway in Western Cape but old challenges linger

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • TB catch-up plan underway in Western Cape but old challenges linger

    In 2019 around 360 000 people in South Africa fell ill with tuberculosis (TB) and about 58 000 people died due to the disease, according to a World Health Organization Report released last week. The COVID-19 pandemic has exacerbated these already alarming numbers, with some TB patients stopping treatment during lockdown. Siyabonga Kamnqa looks at the…

    ·

  • TB treatment time cut by a third

    A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

    ·

  • What is behind SA’s higher TB numbers?

    A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.

    ·

  • Herd (Immunity) Today, Gone Tomorrow

    There is much talk in South Africa about a ‘second wave’ of COVID-19. In Europe, it is much more than talk, with COVID-19 diagnoses, hospital admissions, and deaths, not to mention ‘restrictions’, all on the rise. Alex Welte places in perspective what we do and do not know about herd immunity and potential second waves.

    ·

  • The slow motion race for a TB vaccine

    In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes…

    ·

  • Power grab or tying loose ends? Experts respond to new health regulations

    As Health Minister, Dr Zweli Mkhize’s proposed amendments to regulations on notifiable medical conditions came under fire in Parliament this week, some public health and medical law experts welcomed the proposed amendments to the regulations and even made some suggestions on how it could be improved. Alicestine October took an in-depth look at what is…

    ·

  • The promise of HIV prevention injections and how they work

    Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.

    ·

  • COVID-19: The fascinating science of what happens in the lungs

    People with COVID-19 and people with tuberculosis (TB) can experience similar symptoms such as coughing and breathing difficulties as both diseases affect the lungs. Exactly how these diseases affect the lungs, however, differs. Tiyese Jeranji spoke to a leading South African pulmonologist to learn more.

    ·

  • Competition Commission gets private healthcare reform ball rolling

    A year after the Competition Commission released its Health Market Inquiry (HMI) report, there has been very little action in addressing the report’s findings. Now, a notice the Competition Commission sent to stakeholders in September suggests there may finally be some movement. Elri Voigt reports.

    ·

  • What we know about vaccine hesitancy in South Africa

    A recent global online survey suggests that more than a third of South Africans would not want a COVID-19 vaccine if and when it becomes available. Adele Baleta reports on vaccine hesitancy in South Africa.

    ·